Have your own idea? Try our Stock Screener
Chinese (SSE) Drug Retail Industry Analysis
UpdatedAug 19, 2026
DataAggregated Company Financials
Companies9
- 7D-3.3%
- 3M2.6%
- 1Y-6.4%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 3.3%, driven by a pullback from DaShenLin Pharmaceutical Group of 5.0%. Meanwhile, Sichuan Hezong Medicine Easy-to-buy Pharmaceutical actually outperformed within the industry, gaining 9.7% in the last week. However, the industry is down 6.4% over the past year. Looking forward, earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the Chinese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 19 Aug 2026 | CN¥86.4b | CN¥122.8b | CN¥4.2b | 24.8x | 20.5x | 0.7x |
| Fri, 17 Jul 2026 | CN¥83.1b | CN¥122.8b | CN¥4.2b | 23.9x | 19.8x | 0.7x |
| Sun, 14 Jun 2026 | CN¥80.1b | CN¥122.8b | CN¥4.2b | 23.1x | 19x | 0.7x |
| Tue, 12 May 2026 | CN¥90.1b | CN¥123.1b | CN¥4.2b | 26.6x | 21.5x | 0.7x |
| Thu, 09 Apr 2026 | CN¥89.4b | CN¥121.2b | CN¥3.6b | 25x | 24.8x | 0.7x |
| Sat, 07 Mar 2026 | CN¥92.4b | CN¥121.2b | CN¥3.6b | 26x | 25.7x | 0.8x |
| Mon, 02 Feb 2026 | CN¥95.7b | CN¥121.2b | CN¥3.6b | 27.9x | 26.6x | 0.8x |
| Wed, 31 Dec 2025 | CN¥88.1b | CN¥121.2b | CN¥3.6b | 27.2x | 24.5x | 0.7x |
| Fri, 28 Nov 2025 | CN¥88.8b | CN¥121.2b | CN¥3.6b | 28.9x | 24.7x | 0.7x |
| Sun, 26 Oct 2025 | CN¥91.1b | CN¥120.9b | CN¥3.4b | 28.2x | 27.2x | 0.8x |
| Tue, 23 Sep 2025 | CN¥89.0b | CN¥120.6b | CN¥3.3b | 30.8x | 26.7x | 0.7x |
| Thu, 21 Aug 2025 | CN¥92.6b | CN¥120.5b | CN¥3.2b | 31.7x | 29.3x | 0.8x |
| Sat, 19 Jul 2025 | CN¥90.8b | CN¥120.4b | CN¥3.3b | 31.2x | 27.9x | 0.8x |
| Mon, 16 Jun 2025 | CN¥93.5b | CN¥120.4b | CN¥3.3b | 31.7x | 28.7x | 0.8x |
| Wed, 14 May 2025 | CN¥95.6b | CN¥120.4b | CN¥3.3b | 30.6x | 29.4x | 0.8x |
| Fri, 11 Apr 2025 | CN¥92.6b | CN¥121.0b | CN¥3.9b | 22.9x | 23.7x | 0.8x |
| Sun, 09 Mar 2025 | CN¥82.4b | CN¥121.0b | CN¥3.9b | 18.9x | 21.1x | 0.7x |
| Tue, 04 Feb 2025 | CN¥80.6b | CN¥121.0b | CN¥3.9b | 18.6x | 20.7x | 0.7x |
| Thu, 02 Jan 2025 | CN¥84.7b | CN¥121.0b | CN¥3.9b | 19.7x | 21.7x | 0.7x |
| Sat, 30 Nov 2024 | CN¥89.3b | CN¥121.0b | CN¥3.9b | 19.8x | 22.9x | 0.7x |
| Mon, 28 Oct 2024 | CN¥86.4b | CN¥119.6b | CN¥4.3b | 20x | 20x | 0.7x |
| Wed, 25 Sep 2024 | CN¥72.2b | CN¥119.6b | CN¥4.3b | 16.3x | 16.7x | 0.6x |
| Fri, 23 Aug 2024 | CN¥68.0b | CN¥118.4b | CN¥4.8b | 15.1x | 14.2x | 0.6x |
| Sun, 21 Jul 2024 | CN¥79.3b | CN¥118.4b | CN¥4.8b | 19.1x | 16.5x | 0.7x |
| Tue, 18 Jun 2024 | CN¥100.0b | CN¥118.4b | CN¥4.8b | 23.9x | 20.8x | 0.8x |
| Thu, 16 May 2024 | CN¥127.6b | CN¥118.4b | CN¥4.8b | 26.5x | 26.6x | 1.1x |
| Sat, 13 Apr 2024 | CN¥117.1b | CN¥114.8b | CN¥5.2b | 21.8x | 22.5x | 1x |
| Mon, 11 Mar 2024 | CN¥113.5b | CN¥115.9b | CN¥5.8b | 19.2x | 19.5x | 1x |
| Wed, 07 Feb 2024 | CN¥116.7b | CN¥116.0b | CN¥5.7b | 20.5x | 20.4x | 1x |
| Fri, 05 Jan 2024 | CN¥132.0b | CN¥116.0b | CN¥5.7b | 22.7x | 23x | 1.1x |
| Sun, 03 Dec 2023 | CN¥131.0b | CN¥116.0b | CN¥5.7b | 23x | 22.9x | 1.1x |
| Tue, 31 Oct 2023 | CN¥117.1b | CN¥113.6b | CN¥5.7b | 22.1x | 20.6x | 1x |
| Thu, 28 Sep 2023 | CN¥121.0b | CN¥113.6b | CN¥5.7b | 23x | 21.3x | 1.1x |
| Sat, 26 Aug 2023 | CN¥124.8b | CN¥110.4b | CN¥5.5b | 26.2x | 22.7x | 1.1x |
Price to Earnings Ratio
22.7x
Current Industry PE
- Investors are relatively neutral on the Chinese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 22.8x.
- The industry is trading close to its 3-year average PS ratio of 0.81x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have declined 8.5% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Chinese Drug Retail compare with similar industries?
| CN Market | 2.50% | |
| Consumer Staples | -1.10% | |
| Food and Staples Retail | -0.56% | |
| Drug Retail | -3.33% | |
| Food Distributors | 4.26% | |
| Food Retail | 1.24% | |
| Big Box Super Stores | -1.53% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 300937 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical | CN¥29.83 | 9.7% +CN¥253.5m | -2.5% | PS0.6x | |
| 301408 Anhui Huaren Health Pharmaceutical | CN¥16.59 | 1.8% +CN¥116.0m | 7.7% | PE31.7x |